Phenotypic Switching in Cryptococcus neoformans Contributes to Virulence by Changing the Immunological Host Response
暂无分享,去创建一个
[1] Jianfei Yang,et al. Interleukin 10 suppresses Th17 cytokines secreted by macrophages and T cells , 2008, European journal of immunology.
[2] Gesine Hansen,et al. IL-13 Induces Disease-Promoting Type 2 Cytokines, Alternatively Activated Macrophages and Allergic Inflammation during Pulmonary Infection of Mice with Cryptococcus neoformans1 , 2007, The Journal of Immunology.
[3] A. Casadevall,et al. Capsule Structural Heterogeneity and Antigenic Variation in Cryptococcus neoformans , 2007, Eukaryotic Cell.
[4] Terry B. Strom,et al. IL-21 initiates an alternative pathway to induce proinflammatory TH17 cells , 2007, Nature.
[5] A. Casadevall,et al. The Relative Susceptibility of Mouse Strains to Pulmonary Cryptococcus neoformans Infection Is Associated with Pleiotropic Differences in the Immune Response , 2007, Infection and Immunity.
[6] T. Harrison,et al. Immune dysfunction in HIV-seronegative, Cryptococcus gattii meningitis. , 2007, The Journal of infection.
[7] D. Raoult,et al. The two faces of interleukin 10 in human infectious diseases. , 2006, The Lancet. Infectious diseases.
[8] G. Klintmalm,et al. Systemic and cerebrospinal fluid T-helper cytokine responses in organ transplant recipients with Cryptococcus neoformans infection. , 2006, Transplant immunology.
[9] F. Bistoni,et al. Glucuronoxylomannan exhibits potent immunosuppressive properties. , 2006, FEMS yeast research.
[10] V. Kuchroo,et al. Tim-2 regulates T helper type 2 responses and autoimmunity , 2005, The Journal of experimental medicine.
[11] F. Dromer,et al. Evidence for human immunodeficiency virus and Cryptococcus neoformans interactions in the pro-inflammatory and anti-inflammatory responses in blood during AIDS-associated cryptococcosis. , 2005, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[12] J. Erb-Downward,et al. Distinct Roles for IL-4 and IL-10 in Regulating T2 Immunity during Allergic Bronchopulmonary Mycosis1 , 2005, The Journal of Immunology.
[13] A. Casadevall,et al. Effects of Antifungal Interventions on the Outcome of Experimental Infections with Phenotypic Switch Variants of Cryptococcus neoformans , 2005, Antimicrobial Agents and Chemotherapy.
[14] D. Gordon,et al. Paradoxical inflammatory reaction during treatment of Cryptococcus neoformans var. gattii meningitis in an HIV-seronegative woman. , 2004, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[15] C. Baecher-Allan,et al. T Cell Ig- and Mucin-Domain-Containing Molecule-3 (TIM-3) and TIM-1 Molecules Are Differentially Expressed on Human Th1 and Th2 Cells and in Cerebrospinal Fluid-Derived Mononuclear Cells in Multiple Sclerosis1 , 2004, The Journal of Immunology.
[16] F. Dromer,et al. Cryptococcus neoformans Capsule Structure Evolution In Vitro and during Murine Infection , 2004, Infection and Immunity.
[17] A. Casadevall,et al. The damage-response framework of microbial pathogenesis , 2003, Nature Reviews Microbiology.
[18] A. Casadevall,et al. Phenotypic switching of Cryptococcus neoformans can influence the outcome of the human immune response , 2003, Cellular microbiology.
[19] G. Freeman,et al. The TIM gene family: emerging roles in immunity and disease , 2003, Nature Reviews Immunology.
[20] G. Huffnagle,et al. Effects of Tumor Necrosis Factor Alpha on Dendritic Cell Accumulation in Lymph Nodes Draining the Immunization Site and the Impact on the Anticryptococcal Cell-Mediated Immune Response , 2003, Infection and Immunity.
[21] M. Dorf,et al. Differential Roles of CC Chemokine Ligand 2/Monocyte Chemotactic Protein-1 and CCR2 in the Development of T1 Immunity1 , 2002, The Journal of Immunology.
[22] A. Casadevall,et al. Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection. , 2001, The Journal of clinical investigation.
[23] A. Casadevall,et al. Both Th1 and Th2 Cytokines Affect the Ability of Monoclonal Antibodies To Protect Mice against Cryptococcus neoformans , 2001, Infection and Immunity.
[24] G. Cardinali,et al. Evidence of Microevolution in a Clinical Case of Recurrent Cryptococcus neoformans Meningoencephalitis , 2001, European Journal of Clinical Microbiology and Infectious Diseases.
[25] A. Casadevall,et al. Host-pathogen interactions: the attributes of virulence. , 2001, The Journal of infectious diseases.
[26] M. Olszewski,et al. The Role of Macrophage Inflammatory Protein-1α/CCL3 in Regulation of T Cell-Mediated Immunity to Cryptococcus neoformans Infection1 , 2000, The Journal of Immunology.
[27] C. Mody,et al. Phagocytosis and Protein Processing Are Required for Presentation of Cryptococcus neoformans Mitogen to T Lymphocytes , 2000, Infection and Immunity.
[28] A. Casadevall,et al. Cryptococcus neoformans Is a Facultative Intracellular Pathogen in Murine Pulmonary Infection , 2000, Infection and Immunity.
[29] W. Kuziel,et al. CCR2 Expression Determines T1 Versus T2 Polarization During Pulmonary Cryptococcus neoformans Infection1 , 2000, The Journal of Immunology.
[30] T. Harrison,et al. Effect of interleukin (IL)-15 priming on IL-12 and interferon-gamma production by pathogen-stimulated peripheral blood mononuclear cells from human immunodeficiency virus-seropositive and -seronegative donors. , 2000, The Journal of infectious diseases.
[31] T. Kozel,et al. HIV type 1 envelope glycoprotein gp120 induces development of a T helper type 2 response to Cryptococcus neoformans. , 1999, AIDS.
[32] A. Casadevall,et al. Phenotypic Switching in Cryptococcus neoformansResults in Changes in Cellular Morphology and Glucuronoxylomannan Structure , 1999, Infection and Immunity.
[33] J. Cavaillon,et al. Enhanced Sensitivity of Tumor Necrosis Factor/Lymphotoxin-α—Deficient Mice to Cryptococcus neoformans Infection despite Increased Levels of Nitrite/Nitrate, Interferon-γ, and Interleukin-12 , 1999 .
[34] M. Kurimoto,et al. Interleukin-4 weakens host resistance to pulmonary and disseminated cryptococcal infection caused by combined treatment with interferon-gamma-inducing cytokines. , 1999, Cellular immunology.
[35] C. Mody,et al. The Capsule of Cryptococcus neoformans Reduces T-Lymphocyte Proliferation by Reducing Phagocytosis, Which Can Be Restored with Anticapsular Antibody , 1999, Infection and Immunity.
[36] A. Adesina,et al. Differential Regulation of Immune Responses by Highly and Weakly Virulent Cryptococcus neoformansIsolates , 1999, Infection and Immunity.
[37] H. Okamura,et al. Combined effects of IL‐12 and IL‐18 on the clinical course and local cytokine production in murine pulmonary infection with Cryptococcus neoformans , 1999, European journal of immunology.
[38] A. Casadevall,et al. Phenotypic switching in the human pathogenic fungus Cryptococcus neoformans is associated with changes in virulence and pulmonary inflammatory response in rodents. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[39] A. Casadevall,et al. Serial isolates of Cryptococcus neoformans from patients with AIDS differ in virulence for mice. , 1998, The Journal of infectious diseases.
[40] K. Decken,et al. Interleukin-12 Is Essential for a Protective Th1 Response in Mice Infected with Cryptococcus neoformans , 1998, Infection and Immunity.
[41] A. Casadevall,et al. Organ-Dependent Variation of Capsule Thickness inCryptococcus neoformans during Experimental Murine Infection , 1998, Infection and Immunity.
[42] G. Huffnagle,et al. Cells and cytokines in pulmonary cryptococcosis. , 1998, Research in immunology.
[43] J. Bonnefoy,et al. IgE versus IgG4 production can be differentially regulated by IL-10. , 1998, Journal of immunology.
[44] G. Huffnagle,et al. IL-5 is required for eosinophil recruitment, crystal deposition, and mononuclear cell recruitment during a pulmonary Cryptococcus neoformans infection in genetically susceptible mice (C57BL/6). , 1998, Journal of immunology.
[45] A. Casadevall,et al. Microevolution of a Standard Strain ofCryptococcus neoformans Resulting in Differences in Virulence and Other Phenotypes , 1998, Infection and Immunity.
[46] M. Burdick,et al. Macrophage inflammatory protein-1alpha (MIP-1alpha) is required for the efferent phase of pulmonary cell-mediated immunity to a Cryptococcus neoformans infection. , 1997, Journal of immunology.
[47] K. Kawakami,et al. Expression of cytokines and inducible nitric oxide synthase mRNA in the lungs of mice infected with Cryptococcus neoformans: effects of interleukin-12 , 1997, Infection and immunity.
[48] M. Burdick,et al. Afferent phase production of TNF-alpha is required for the development of protective T cell immunity to Cryptococcus neoformans. , 1996, Journal of immunology.
[49] A. Casadevall,et al. Pathology of cryptococcal meningoencephalitis: analysis of 27 patients with pathogenetic implications. , 1996, Human pathology.
[50] F. Dromer,et al. Epidemiology of cryptococcosis in France: a 9-year survey (1985-1993). French Cryptococcosis Study Group. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[51] G. Huffnagle,et al. Early cytokine production in pulmonary Cryptococcus neoformans infections distinguishes susceptible and resistant mice. , 1995, American journal of respiratory cell and molecular biology.
[52] J. Curtis,et al. Down-regulation of the afferent phase of T cell-mediated pulmonary inflammation and immunity by a high melanin-producing strain of Cryptococcus neoformans. , 1995, Journal of immunology.
[53] B. Wallaert,et al. Cytokines and cytokine network in silicosis and coal workers' pneumoconiosis. , 1995, The European respiratory journal.
[54] A. Casadevall,et al. Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis , 1995, Infection and immunity.
[55] K. Buchanan,et al. Regulation of cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response , 1994, Infection and immunity.
[56] G. Huffnagle,et al. The role of CD4+ and CD8+ T cells in the protective inflammatory response to a pulmonary cryptococcal infection , 1994, Journal of leukocyte biology.
[57] J. Murphy. Cytokine profiles associated with induction of the anticryptococcal cell-mediated immune response , 1993, Infection and immunity.
[58] K. Buchanan,et al. Characterization of cellular infiltrates and cytokine production during the expression phase of the anticryptococcal delayed-type hypersensitivity response , 1993, Infection and immunity.
[59] C. Mody,et al. Effect of polysaccharide capsule and methods of preparation on human lymphocyte proliferation in response to Cryptococcus neoformans , 1993, Infection and immunity.
[60] A. Luca,et al. IL-17 and Therapeutic Kynurenines in Pathogenic Inflammation to Fungi , 2008 .
[61] F. Bistoni,et al. Interleukin-12 counterbalances the deleterious effect of human immunodeficiency virus type 1 envelope glycoprotein gp120 on the immune response to Cryptococcus neoformans. , 2001, The Journal of infectious diseases.
[62] H. Okamura,et al. Role of TNF-alpha in the induction of fungicidal activity of mouse peritoneal exudate cells against Cryptococcus neoformans by IL-12 and IL-18. , 1999, Cellular immunology.
[63] J. Cavaillon,et al. Enhanced sensitivity of tumor necrosis factor/lymphotoxin-alpha-deficient mice to Cryptococcus neoformans infection despite increased levels of nitrite/nitrate, interferon-gamma, and interleukin-12. , 1999, The Journal of infectious diseases.
[64] Jay K Kolls,et al. The Biological Functions of T Helper 17 Cell Effector Cytokines in Inflammation , 2022 .